SG Digest: Dun & Bradstreet buys Eyeota; Zuellig Pharma exits Klinify

SG Digest: Dun & Bradstreet buys Eyeota; Zuellig Pharma exits Klinify

Photo by Markus Spiske on Unsplash

US-based Dun & Bradstreet Holdings Inc announced that it has entered into a definitive agreement to acquire Singapore-based data transformation company Eyeota. In a separate development, healthcare services provider Zuellig Pharma has sold its entire stake in healthtech startup Klinify to Hong Kong-based Heals Healthcare.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter